Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
    November 2017
  1. WAN L, Yu W, Shen E, Sun W, et al
    SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
    Gut. 2017 Nov 7. pii: gutjnl-2017-314983. doi: 10.1136/gutjnl-2017-314983.
    >> Share

  2. GUNDERT M, Edelmann D, Benner A, Jansen L, et al
    Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gut. 2017 Nov 3. pii: gutjnl-2017-314711. doi: 10.1136/gutjnl-2017-314711.
    >> Share

  3. ZORZI M, Hassan C, Capodaglio G, Fedato C, et al
    Long-term performance of colorectal cancer screening programmes based on the faecal immunochemical test.
    Gut. 2017 Nov 3. pii: gutjnl-2017-314753. doi: 10.1136/gutjnl-2017-314753.
    >> Share

    October 2017
  4. MAZARD T, Boonsirikamchai P, Overman MJ, Asran MA, et al
    Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
    Gut. 2017 Oct 30. pii: gutjnl-2017-313786. doi: 10.1136/gutjnl-2017-313786.
    >> Share

    Integrin alpha6 variants and colorectal cancer.
    Gut. 2017 Oct 28. pii: gutjnl-2017-315415. doi: 10.1136/gutjnl-2017-315415.
    >> Share

  6. SCHRAMM C, Janhsen K, Demir M, Nierhoff D, et al
    Serrated polyposis syndrome may go undiagnosed even in structured colorectal cancer screening programmes performed by endoscopists with otherwise good quality indices.
    Gut. 2017 Oct 21. pii: gutjnl-2017-315321. doi: 10.1136/gutjnl-2017-315321.
    >> Share

  7. FLEMER B, Warren RD, Barrett MP, Cisek K, et al
    The oral microbiota in colorectal cancer is distinctive and predictive.
    Gut. 2017 Oct 7. pii: gutjnl-2017-314814. doi: 10.1136/gutjnl-2017-314814.
    >> Share

  8. BARAULT L, Amatu A, Siravegna G, Ponzetti A, et al
    Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.
    Gut. 2017 Oct 5. pii: gutjnl-2016-313372. doi: 10.1136/gutjnl-2016-313372.
    >> Share

    August 2017
  9. DIGBY J, Fraser CG, Carey FA, Steele RJC, et al
    Can the performance of a quantitative FIT-based colorectal cancer screening programme be enhanced by lowering the threshold and increasing the interval?
    Gut. 2017 Aug 24. pii: gutjnl-2017-314862. doi: 10.1136/gutjnl-2017-314862.
    >> Share

  10. KHAN K, Rata M, Cunningham D, Koh DM, et al
    Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314178. doi: 10.1136/gutjnl-2017-314178.
    >> Share

    July 2017
  11. YANG W, Liu L, Masugi Y, Qian ZR, et al
    Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR).
    Gut. 2017 Jul 4. pii: gutjnl-2017-314163. doi: 10.1136/gutjnl-2017-314163.
    >> Share

  12. EAST JE, Atkin WS, Bateman AC, Clark SK, et al
    British Society of Gastroenterology position statement on serrated polyps in the colon and rectum.
    Gut. 2017;66:1181-1196.
    >> Share

    June 2017
  13. HAWINKELS LJ, Hardwick JC
    Putting the Wnt up colon cancer.
    Gut. 2017;66:983-984.
    >> Share

  14. ADAMS LA, Anstee QM, Tilg H, Targher G, et al
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
    Gut. 2017;66:1138-1153.
    >> Share

    May 2017
  15. OMAR AL-HASSI H, Ng O, Brookes M
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017 May 4. pii: gutjnl-2017-314219. doi: 10.1136/gutjnl-2017-314219.
    >> Share

  16. PARANG B, Kaz AM, Barrett CW, Short SP, et al
    BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.
    Gut. 2017;66:852-862.
    >> Share

  17. REES CJ, Rajasekhar PT, Wilson A, Close H, et al
    Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study.
    Gut. 2017;66:887-895.
    >> Share

    April 2017
  18. MANIC G, Signore M, Sistigu A, Russo G, et al
    CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.
    Gut. 2017 Apr 7. pii: gutjnl-2016-312623. doi: 10.1136/gutjnl-2016-312623.
    >> Share

  19. DE BARRIOS O, Gyorffy B, Fernandez-Acenero MJ, Sanchez-Tillo E, et al
    ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.
    Gut. 2017;66:666-682.
    >> Share

  20. FLEMER B, Lynch DB, Brown JM, Jeffery IB, et al
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2017;66:633-643.
    >> Share

  21. ARNOLD M, Sierra MS, Laversanne M, Soerjomataram I, et al
    Global patterns and trends in colorectal cancer incidence and mortality.
    Gut. 2017;66:683-691.
    >> Share

  22. PELLISE M, Burgess NG, Tutticci N, Hourigan LF, et al
    Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions.
    Gut. 2017;66:644-653.
    >> Share

  23. AMICARELLA F, Muraro MG, Hirt C, Cremonesi E, et al
    Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
    Gut. 2017;66:692-704.
    >> Share

  24. HUR K, Toiyama Y, Okugawa Y, Ide S, et al
    Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Gut. 2017;66:654-665.
    >> Share

    March 2017
  25. SAKUMA K, Sasaki E, Kimura K, Komori K, et al
    HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition.
    Gut. 2017 Mar 30. pii: gutjnl-2016-312927. doi: 10.1136/gutjnl-2016-312927.
    >> Share

  26. SHAH MS, DeSantis TZ, Weinmaier T, McMurdie PJ, et al
    Leveraging sequence-based faecal microbial community survey data to identify a composite biomarker for colorectal cancer.
    Gut. 2017 Mar 24. pii: gutjnl-2016-313189. doi: 10.1136/gutjnl-2016-313189.
    >> Share

    Race-specific differences in mucosal sulfidogenic bacteria modify colon cancer risk.
    Gut. 2017 Mar 20. pii: gutjnl-2017-313989. doi: 10.1136/gutjnl-2017-313989.
    >> Share

  28. MENNONNA D, Maccalli C, Romano MC, Garavaglia C, et al
    T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.
    Gut. 2017;66:454-463.
    >> Share

  29. VAN DOORN SC, van der Vlugt M, Depla A, Wientjes CA, et al
    Adenoma detection with Endocuff colonoscopy versus conventional colonoscopy: a multicentre randomised controlled trial.
    Gut. 2017;66:438-445.
    >> Share

  30. GUPTA S, Jacobs ET, Baron JA, Lieberman DA, et al
    Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis.
    Gut. 2017;66:446-453.
    >> Share

  31. MOLLER P, Seppala T, Bernstein I, Holinski-Feder E, et al
    Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
    Gut. 2017;66:464-472.
    >> Share

    February 2017
  32. SIRAJ AK, Masoodi T, Bu R, Pratheeshkumar P, et al
    MED12 is recurrently mutated in Middle Eastern colorectal cancer.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313334. doi: 10.1136/gutjnl-2016-313334.
    >> Share

  33. YAZICI C, Wolf PG, Kim H, Cross TL, et al
    Race-dependent association of sulfidogenic bacteria with colorectal cancer.
    Gut. 2017 Feb 2. pii: gutjnl-2016-313321. doi: 10.1136/gutjnl-2016-313321.
    >> Share

  34. RADAELLI F, Paggi S, Hassan C, Senore C, et al
    Split-dose preparation for colonoscopy increases adenoma detection rate: a randomised controlled trial in an organised screening programme.
    Gut. 2017;66:270-277.
    >> Share

  35. IJSPEERT JE, Rana SA, Atkinson NS, van Herwaarden YJ, et al
    Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.
    Gut. 2017;66:278-284.
    >> Share

  36. CHIU SY, Chuang SL, Chen SL, Yen AM, et al
    Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Gut. 2017;66:293-300.
    >> Share

  37. ROY HK, Turzhitsky V, Wali R, Radosevich AJ, et al
    Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.
    Gut. 2017;66:285-292.
    >> Share

    January 2017
    Colorectal cancer cells use the negative feedback regulators of WNT signalling to activate epithelial-mesenchymal transition pathways.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313185. doi: 10.1136/gutjnl-2016-313185.
    >> Share

  39. DE KLERK CM, Gupta S, Dekker E, Essink-Bot ML, et al
    Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313311. doi: 10.1136/gutjnl-2016-313311.
    >> Share

  40. BETTINGTON M, Walker N, Rosty C, Brown I, et al
    Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma.
    Gut. 2017;66:97-106.
    >> Share

  41. OKUGAWA Y, Toiyama Y, Toden S, Mitoma H, et al
    Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Gut. 2017;66:107-117.
    >> Share

  42. YU J, Feng Q, Wong SH, Zhang D, et al
    Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer.
    Gut. 2017;66:70-78.
    >> Share

  43. KAPIDZIC A, van Roon AH, van Leerdam ME, van Vuuren AJ, et al
    Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.
    Gut. 2017;66:118-123.
    >> Share

    December 2016
  44. PASSAMONTI B, Malaspina M, Fraser CG, Tintori B, et al
    A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Gut. 2016 Dec 14. pii: gutjnl-2016-312716. doi: 10.1136/gutjnl-2016-312716.
    >> Share

    November 2016
  45. COLUSSI D, Zagari RM, Morini B, Fabbri M, et al
    Prevalence of serrated polyposis syndrome in an FIT-based colorectal cancer screening cohort in Italy.
    Gut. 2016 Nov 15. pii: gutjnl-2016-313063. doi: 10.1136/gutjnl-2016-313063.
    >> Share

  46. HUANG Y, Zhou J, Luo S, Wang Y, et al
    Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Gut. 2016 Nov 14. pii: gutjnl-2016-311909. doi: 10.1136/gutjnl-2016-311909.
    >> Share

  47. RHO JH, Ladd JJ, Li CI, Potter JD, et al
    Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Gut. 2016 Nov 7. pii: gutjnl-2016-312794. doi: 10.1136/gutjnl-2016-312794.
    >> Share

    October 2016
  48. NULSEN B, Lewis B
    Response to: 'Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme' by Hassan et al.
    Gut. 2016 Oct 24. pii: gutjnl-2016-313117. doi: 10.1136/gutjnl-2016-313117.
    >> Share

  49. DOWNING A, Morris EJ, Corrigan N, Sebag-Montefiore D, et al
    High hospital research participation and improved colorectal cancer survival outcomes: a population-based study.
    Gut. 2016 Oct 19. pii: gutjnl-2015-311308. doi: 10.1136/gutjnl-2015-311308.
    >> Share

  50. DOUBENI CA, Corley DA, Quinn VP, Jensen CD, et al
    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.
    Gut. 2016 Oct 12. pii: gutjnl-2016-312712. doi: 10.1136/gutjnl-2016-312712.
    >> Share

    September 2016
  51. BOROVSKI T, Vellinga TT, Laoukili J, Santo EE, et al
    Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311547. doi: 10.1136/gutjnl-2016-311547.
    >> Share

  52. LINDNER AU, Salvucci M, Morgan C, Monsefi N, et al
    BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Gut. 2016 Sep 23. pii: gutjnl-2016-312287. doi: 10.1136/gutjnl-2016-312287.
    >> Share

    August 2016
  53. GROBBEE EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, et al
    A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311819. doi: 10.1136/gutjnl-2016-311819.
    >> Share

  54. HASSAN C, Senore C, Radaelli F, De Pretis G, et al
    Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311906. doi: 10.1136/gutjnl-2016-311906.
    >> Share

    July 2016
  55. GRILLET F, Bayet E, Villeronce O, Zappia L, et al
    Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.
    Gut. 2016 Jul 25. pii: gutjnl-2016-311447. doi: 10.1136/gutjnl-2016-311447.
    >> Share

  56. SONG M, Zhang X, Meyerhardt JA, Giovannucci EL, et al
    Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.
    Gut. 2016 Jul 19. pii: gutjnl-2016-311990. doi: 10.1136/gutjnl-2016-311990.
    >> Share

  57. DE ARCANGELIS A, Hamade H, Alpy F, Normand S, et al
    Hemidesmosome integrity protects the colon against colitis and colorectal cancer.
    Gut. 2016 Jul 1. pii: gutjnl-2015-310847. doi: 10.1136/gutjnl-2015-310847.
    >> Share

    May 2016
  58. MASUGI Y, Nishihara R, Yang J, Mima K, et al
    Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Gut. 2016 May 5. pii: gutjnl-2016-311421. doi: 10.1136/gutjnl-2016-311421.
    >> Share

    April 2016
  59. KAMINSKI MF, Anderson J, Valori R, Kraszewska E, et al
    Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial.
    Gut. 2016;65:616-24.
    >> Share

    March 2016
  60. BURGESS NG, Pellise M, Nanda KS, Hourigan LF, et al
    Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps.
    Gut. 2016;65:437-46.
    >> Share

  61. FACCIORUSSO A, Ferrusquia J, Muscatiello N
    Lead time bias in estimating survival outcomes.
    Gut. 2016;65:538-9.
    >> Share

    February 2016
  62. SONG M, Nishihara R, Wang M, Chan AT, et al
    Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Gut. 2016;65:296-304.
    >> Share

  63. COUGNOUX A, Delmas J, Gibold L, Fais T, et al
    Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
    Gut. 2016;65:278-85.
    >> Share

  64. DORIA-ROSE VP, Levin TR, Palitz A, Conell C, et al
    Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
    Gut. 2016;65:271-7.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016